BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1460 related articles for article (PubMed ID: 34727554)

  • 21. Coronavirus Disease 2019 (COVID-19) Vaccines and Pregnancy: What Obstetricians Need to Know.
    Rasmussen SA; Kelley CF; Horton JP; Jamieson DJ
    Obstet Gynecol; 2021 Mar; 137(3):408-414. PubMed ID: 33370015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021.
    Dooling K; Gargano JW; Moulia D; Wallace M; Rosenblum HG; Blain AE; Hadler SC; Plumb ID; Moline H; Gerstein J; Collins JP; Godfrey M; Campos-Outcalt D; Morgan RL; Brooks O; Talbot HK; Lee GM; Daley MF; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1344-1348. PubMed ID: 34555007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years - COVID-NET, 13 States, February-April 2021.
    Moline HL; Whitaker M; Deng L; Rhodes JC; Milucky J; Pham H; Patel K; Anglin O; Reingold A; Chai SJ; Alden NB; Kawasaki B; Meek J; Yousey-Hindes K; Anderson EJ; Farley MM; Ryan PA; Kim S; Nunez VT; Como-Sabetti K; Lynfield R; Sosin DM; McMullen C; Muse A; Barney G; Bennett NM; Bushey S; Shiltz J; Sutton M; Abdullah N; Talbot HK; Schaffner W; Chatelain R; Ortega J; Murthy BP; Zell E; Schrag SJ; Taylor C; Shang N; Verani JR; Havers FP
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1088-1093. PubMed ID: 34383730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Counseling in maternal-fetal medicine: SARS-CoV-2 infection in pregnancy.
    Di Mascio D; Buca D; Berghella V; Khalil A; Rizzo G; Odibo A; Saccone G; Galindo A; Liberati M; D'Antonio F
    Ultrasound Obstet Gynecol; 2021 May; 57(5):687-697. PubMed ID: 33724545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative Profiles of SARS-CoV-2 Spike-Specific Human Milk Antibodies Elicited by mRNA- and Adenovirus-Based COVID-19 Vaccines.
    Yang X; Fox A; DeCarlo C; Norris C; Griffin S; Wedekind S; Flanagan JM; Shenker N; Powell RL
    Breastfeed Med; 2022 Aug; 17(8):638-646. PubMed ID: 35675683
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
    Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Race for COVID-19 Vaccines: The Various Types and Their Strengths and Weaknesses.
    Muhar BK; Nehira J; Malhotra A; Kotchoni SO
    J Pharm Pract; 2023 Aug; 36(4):953-966. PubMed ID: 35723017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 Infection.
    Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Briker SM; Triebwasser JE; Gerber JS; Morris JS; Weirick ME; McAllister CM; Hensley SE; Puopolo KM
    JAMA Netw Open; 2022 Nov; 5(11):e2240993. PubMed ID: 36350652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.
    Rosenblum HG; Wallace M; Godfrey M; Roper LE; Hall E; Fleming-Dutra KE; Link-Gelles R; Pilishvili T; Williams J; Moulia DL; Brooks O; Talbot HK; Lee GM; Bell BP; Daley MF; Meyer S; Oliver SE; Twentyman E
    MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(45):1436-1441. PubMed ID: 36355612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.
    Bookstein Peretz S; Regev N; Novick L; Nachshol M; Goffer E; Ben-David A; Asraf K; Doolman R; Levin EG; Regev Yochay G; Yinon Y
    Ultrasound Obstet Gynecol; 2021 Sep; 58(3):450-456. PubMed ID: 34198360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
    Hsu CM; Weiner DE; Manley HJ; Aweh GN; Ladik V; Frament J; Miskulin D; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK
    Clin J Am Soc Nephrol; 2022 Mar; 17(3):403-413. PubMed ID: 35144972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnancy Status at the Time of Coronavirus Disease 2019 Vaccination and Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Magnus MC; Håberg SE; Carlsen EØ; Kwong JC; Buchan SA; Fell DB
    Clin Infect Dis; 2023 Jan; 76(1):57-65. PubMed ID: 36071540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Risk of Hospitalization and Mortality After Breakthrough SARS-CoV-2 Infection by Vaccine Type: Observational Study of Medical Claims Data.
    Kshirsagar M; Nasir M; Mukherjee S; Becker N; Dodhia R; Weeks WB; Ferres JL; Richardson B
    JMIR Public Health Surveill; 2022 Nov; 8(11):e38898. PubMed ID: 36265135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preserved recognition of Omicron spike following COVID-19 messenger RNA vaccination in pregnancy.
    Bartsch YC; Atyeo C; Kang J; Cai Y; Chen B; Gray KJ; Edlow AG; Alter G
    Am J Obstet Gynecol; 2022 Sep; 227(3):493.e1-493.e7. PubMed ID: 35430229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Professionally responsible coronavirus disease 2019 vaccination counseling of obstetrical and gynecologic patients.
    Chervenak FA; McCullough LB; Bornstein E; Johnson L; Katz A; McLeod-Sordjan R; Nimaroff M; Rochelson BL; Tekbali A; Warman A; Williams K; Grünebaum A
    Am J Obstet Gynecol; 2021 May; 224(5):470-478. PubMed ID: 33539825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries.
    Skjefte M; Ngirbabul M; Akeju O; Escudero D; Hernandez-Diaz S; Wyszynski DF; Wu JW
    Eur J Epidemiol; 2021 Feb; 36(2):197-211. PubMed ID: 33649879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022.
    Hause AM; Marquez P; Zhang B; Myers TR; Gee J; Su JR; Blanc PG; Thomas A; Thompson D; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(44):1401-1406. PubMed ID: 36327162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Vaccine Reactions After COVID-19 Vaccine Booster Doses Among Pregnant and Lactating Individuals.
    Kachikis A; Englund JA; Covelli I; Frank Y; Haghighi C; Singleton M; Drake AL; Eckert LO
    JAMA Netw Open; 2022 Sep; 5(9):e2230495. PubMed ID: 36074467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 73.